本文選題：宮頸癌　切入點(diǎn)：生物標(biāo)志物　出處：《現(xiàn)代預(yù)防醫(yī)學(xué)》2015年11期 　論文類型：期刊論文

【摘要】：宮頸癌是一種常見的婦科惡性腫瘤,其發(fā)病率位于女性腫瘤第二位,僅次于乳腺癌。目前宮頸癌呈年輕化的趨勢(shì),鑒于宮頸癌的早期治愈率很高,早發(fā)現(xiàn)早治療是應(yīng)對(duì)宮頸癌的最有效方式,但目前的宮頸涂片檢查敏感度低,重復(fù)性差等特點(diǎn)是制約早期診斷的一個(gè)重要瓶頸。人乳頭瘤病毒的感染是宮頸癌發(fā)生的明確病因,因此,尋找人乳頭瘤病毒調(diào)節(jié)的生物標(biāo)志物對(duì)于疾病的早期發(fā)現(xiàn)、預(yù)防、治療以及預(yù)后都有著十分重要的意義。在此,本文對(duì)宮頸癌的一些特異性分子標(biāo)志物進(jìn)行了總結(jié),這些標(biāo)志物的順利開發(fā)在臨床檢測(cè)和治療上有著非常重要的意義。
[Abstract]:Cervical cancer is a common gynecologic malignant tumor, its incidence rate is the second highest in women, second only to breast cancer. At present, cervical cancer is becoming younger, since the early cure rate of cervical cancer is very high. Early detection and early treatment is the most effective way to deal with cervical cancer. However, the characteristics of low sensitivity and poor reproducibility of cervical smear are an important bottleneck restricting early diagnosis. The infection of human papillomavirus is the clear cause of cervical cancer. Therefore, searching for biomarkers of human papillomavirus regulation plays an important role in the early detection, prevention, treatment and prognosis of cervical cancer. The successful development of these markers is of great significance in clinical detection and treatment.
【作者單位】： 衡水市第四人民醫(yī)院婦產(chǎn)科;
【分類號(hào)】：R737.33

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王有良;朱一劍;丁顯平;;L1、E6和E7基因序列分析[J];成都醫(yī)學(xué)院學(xué)報(bào);2013年03期

2 張q，

本文編號(hào)：1558121